Clinical trial
The Preoperative Administration of ICG (Indocyanine Green) Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.
NCT06398028 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Preoperative Administration of ICG (Indocyanine Green) Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- August 19, 2023
- Completion date
- March 19, 2028
- Enrollment
- 173 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver tumor; surgery